Related Articles
Evaluation of histochemical anthracyclin binding as potential prognostic parameter in small cell lung cancer.
Resistance to epithelial growth factor receptor tyrosine kinase inhibitors in a patient with transformation from lung adenocarcinoma to small cell lung cancer: A case report
Impaired ζ chain expression and IFN-γ production in peripheral blood T and NK cells of patients with advanced lung cancer
Cut-off levels of NSE to differentiate SCLC from NSCLC
Transformation to small‑cell lung cancer following treatment with icotinib in a patient with lung adenocarcinoma